Research [ASAP] Chk1-Targeted Hesperidin Liposomes for Breast Cancer Therapy: An Integrated In Silico, In Vitro, and In Vivo Evaluation LikeLiked Date: May 21, 2026 Less than 1 MinRead Views: 14 ACS Applied Bio Materials DOI: 10.1021/acsabm.6c00143 Source: http://dx.doi.org/10.1021/acsabm.6c00143 FacebookTwitterLinkedinWhatsAppTelegramEmail ALT-Lab-Ad-1ALT-Lab-Ad-2ALT-Lab-Ad-3ALT-Lab-Ad-4ALT-Lab-Ad-5ALT-Lab-Ad-6ALT-Lab-Ad-7ALT-Lab-Ad-8ALT-Lab-Ad-9ALT-Lab-Ad-10ALT-Lab-Ad-11ALT-Lab-Ad-12ALT-Lab-Ad-13 Recent Articles John Deere’s new 6R utility tractor ‘power-dense’ Food & Agriculture August 31, 2026 When ocean temperatures increase, so does child malnutrition on land Environmental News August 31, 2026 Manhattan’s flood walls are almost done. What will Mamdani do next? Environmental News August 31, 2026 Hydrogen Gets Far More Attention Than Its Deployment Justifies Clean Tech August 31, 2026 New Machine Learning Models Improve Real-Time Nuclear Chemical Monitoring Research August 31, 2026 Ceramic Battery Breakthrough Powers the Future of Reliable Electric Transportation Research August 31, 2026 Waste Management Compliance Audit | Roadrunner Waste Management August 31, 2026 China’s new rules give smart-vehicle sensors more design freedom Electric Vehicles August 31, 2026 SpeedyIndex Brings AI Agents to Link Building: Donor Domains to Be Scored by Long-Term Indexing Health Materials & Chemicals August 31, 2026 BYD reportedly to take Racco electric K-Car tech global for small EVs Electric Vehicles August 31, 2026 Load more
